These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

529 related articles for article (PubMed ID: 26855006)

  • 21. Intensity-modulated radiotherapy: is xerostomia still prevalent?
    Chambers MS; Garden AS; Rosenthal D; Ahamad A; Schwartz DL; Blanco AI; Chao KS; Morrison WH; Ang KK; Weber RS
    Curr Oncol Rep; 2005 Mar; 7(2):131-6. PubMed ID: 15717947
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Changes in salivary gland function after radiotherapy of head and neck tumors measured by quantitative pertechnetate scintigraphy: comparison of intensity-modulated radiotherapy and conventional radiation therapy with and without Amifostine.
    Münter MW; Hoffner S; Hof H; Herfarth KK; Haberkorn U; Rudat V; Huber P; Debus J; Karger CP
    Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):651-9. PubMed ID: 17175118
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intensity-modulated radiation therapy and xerostomia.
    Chambers MS; Weber RS; Garden AS
    J Calif Dent Assoc; 2006 Sep; 34(9):743-8. PubMed ID: 17022299
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proton beam radiation therapy results in significantly reduced toxicity compared with intensity-modulated radiation therapy for head and neck tumors that require ipsilateral radiation.
    Romesser PB; Cahlon O; Scher E; Zhou Y; Berry SL; Rybkin A; Sine KM; Tang S; Sherman EJ; Wong R; Lee NY
    Radiother Oncol; 2016 Feb; 118(2):286-92. PubMed ID: 26867969
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Parotid gland sparing with helical tomotherapy in head-and-neck cancer.
    Voordeckers M; Farrag A; Everaert H; Tournel K; Storme G; Verellen D; De Ridder M
    Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):443-8. PubMed ID: 22836056
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recurrences near base of skull after IMRT for head-and-neck cancer: implications for target delineation in high neck and for parotid gland sparing.
    Eisbruch A; Marsh LH; Dawson LA; Bradford CR; Teknos TN; Chepeha DB; Worden FP; Urba S; Lin A; Schipper MJ; Wolf GT
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):28-42. PubMed ID: 15093896
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Salivary gland-sparing other than parotid-sparing in definitive head-and-neck intensity-modulated radiotherapy does not seem to jeopardize local control.
    Chajon E; Lafond C; Louvel G; Castelli J; Williaume D; Henry O; Jégoux F; Vauléon E; Manens JP; Le Prisé E; de Crevoisier R
    Radiat Oncol; 2013 May; 8():132. PubMed ID: 23721062
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Can dose reduction to one parotid gland prevent xerostomia?--A feasibility study for locally advanced head and neck cancer patients treated with intensity-modulated radiotherapy.
    Anand AK; Jain J; Negi PS; Chaudhoory AR; Sinha SN; Choudhury PS; Kumar R; Munjal RK
    Clin Oncol (R Coll Radiol); 2006 Aug; 18(6):497-504. PubMed ID: 16909975
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Smart (simultaneous modulated accelerated radiation therapy) boost: a new accelerated fractionation schedule for the treatment of head and neck cancer with intensity modulated radiotherapy.
    Butler EB; Teh BS; Grant WH; Uhl BM; Kuppersmith RB; Chiu JK; Donovan DT; Woo SY
    Int J Radiat Oncol Biol Phys; 1999 Aug; 45(1):21-32. PubMed ID: 10477002
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Intensity-modulated radiotherapy for head and neck cancer. Dose constraint for salivary gland and mandible].
    Pointreau Y; Lizée T; Bensadoun RJ; Boisselier P; Racadot S; Thariat J; Graff P
    Cancer Radiother; 2016 Oct; 20(6-7):445-51. PubMed ID: 27614524
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Unilateral and bilateral neck SIB for head and neck cancer patients : Intensity-modulated proton therapy, tomotherapy, and RapidArc.
    Stromberger C; Cozzi L; Budach V; Fogliata A; Ghadjar P; Wlodarczyk W; Jamil B; Raguse JD; Böttcher A; Marnitz S
    Strahlenther Onkol; 2016 Apr; 192(4):232-9. PubMed ID: 26852243
    [TBL] [Abstract][Full Text] [Related]  

  • 32.
    Qiu J; Lv B; Fu M; Wang X; Zheng X; Zhuo W
    Head Neck; 2017 Dec; 39(12):2519-2527. PubMed ID: 28963789
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radiation-induced volume changes in parotid and submandibular glands in patients with head and neck cancer receiving postoperative radiotherapy: a longitudinal study.
    Wang ZH; Yan C; Zhang ZY; Zhang CP; Hu HS; Kirwan J; Mendenhall WM
    Laryngoscope; 2009 Oct; 119(10):1966-74. PubMed ID: 19688858
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Real-life assessment of Volumetric Modulated Arc Therapy (VMAT) toxicity in Head and Neck Squamous Cell Carcinoma (HNSCC) treatment.
    Moncharmont C; Vallard A; Mengue Ndong S; Guy JB; Saget C; Méry B; Langrand-Escure J; de Laroche G; Goyet D; Prades JM; Fournel P; Magné N
    Acta Otolaryngol; 2016; 136(2):181-8. PubMed ID: 26503806
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A prospective study of weekly intensity modulated radiation therapy plan adaptation for head and neck cancer: improved target coverage and organ at risk sparing.
    Aly F; Miller AA; Jameson MG; Metcalfe PE
    Australas Phys Eng Sci Med; 2019 Mar; 42(1):43-51. PubMed ID: 30406923
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preservation of oral health-related quality of life and salivary flow rates after inverse-planned intensity- modulated radiotherapy (IMRT) for head-and-neck cancer.
    Parliament MB; Scrimger RA; Anderson SG; Kurien EC; Thompson HK; Field GC; Hanson J
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):663-73. PubMed ID: 14967418
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reducing xerostomia after chemo-IMRT for head-and-neck cancer: beyond sparing the parotid glands.
    Little M; Schipper M; Feng FY; Vineberg K; Cornwall C; Murdoch-Kinch CA; Eisbruch A
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):1007-14. PubMed ID: 22056067
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of full-neck volumetric-modulated arc therapy vs split-field intensity-modulated head and neck radiation therapy on low neck targets and structures.
    Anamalayil SJ; Teo BK; Lin A; Lustig RA; Ahn PH
    Br J Radiol; 2016 Jun; 89(1062):20160009. PubMed ID: 27043353
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multi-isocentric 4π volumetric-modulated arc therapy approach for head and neck cancer.
    Subramanian VS; Subramani V; Chilukuri S; Kathirvel M; Arun G; Swamy ST; Subramanian K; Fogliata A; Cozzi L
    J Appl Clin Med Phys; 2017 Sep; 18(5):293-300. PubMed ID: 28834021
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tubarial salivary gland sparing with proton therapy.
    Wright CM; Lee DY; Kim M; Barsky AR; Teo BK; Lukens JN; Swisher-McClure S; Lin A
    Med Dosim; 2022 Autumn; 47(3):222-226. PubMed ID: 35428548
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.